Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant

N Engl J Med. 2021 Jan 14;384(2):e14. doi: 10.1056/NEJMe2100736.
No abstract available

Publication types

  • Editorial
  • Interview

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / therapeutic use
  • Africa / epidemiology
  • Age Factors
  • Alanine / analogs & derivatives
  • Alanine / therapeutic use
  • Antibodies, Neutralizing
  • Azabicyclo Compounds / therapeutic use
  • COVID-19 Testing
  • COVID-19 Vaccines / administration & dosage
  • COVID-19 Vaccines / adverse effects
  • COVID-19 Vaccines / immunology*
  • COVID-19* / epidemiology
  • COVID-19* / prevention & control
  • COVID-19* / therapy
  • COVID-19* / transmission
  • Communicable Disease Control / methods*
  • Dexamethasone / therapeutic use
  • Disease Transmission, Infectious / prevention & control
  • Disease Transmission, Infectious / statistics & numerical data
  • Humans
  • Immunization Programs / organization & administration*
  • Mutation
  • Patient Acuity
  • Quinazolines / therapeutic use
  • Risk Factors
  • SARS-CoV-2* / genetics
  • SARS-CoV-2* / immunology
  • SARS-CoV-2* / pathogenicity
  • SARS-CoV-2* / ultrastructure
  • Sequence Analysis, RNA
  • South Africa / epidemiology
  • Virulence / genetics

Substances

  • Antibodies, Neutralizing
  • Azabicyclo Compounds
  • COVID-19 Vaccines
  • Quinazolines
  • remdesivir
  • Adenosine Monophosphate
  • Dexamethasone
  • XL647
  • Alanine